Selecting a CDMO: A Guide to Successful Collaboration

Learn to navigate the complexities of selecting a CDMO in this upcoming webinar. We’ll delve into the key criteria for choosing a drug development, manufacturing, and commercialization partner, and we’ll demonstrate how to choose a CDMO that can help you cut costs, expedite time-to-market, and supercharge your product’s success. On Thursday, July 13, join Dr. Srinivasan Shanmugam as he guides the audience through the CDMO selection process and arms them with strategies to avoid common pitfalls.

•••

This webinar will focus on the critical considerations when choosing a CDMO for a successful partnership. Selecting the right CDMO is crucial for a sponsor or outsourcing company, as it significantly affects the product’s success, cost, and time to market.

Creating a solid business partnership case for potential CDMOs is vital, as it showcases the company’s strengths, needs, and expectations. It also offers an opportunity to assess the CDMO’s capabilities and expertise, their approach to collaboration and communication and their alignment with the company’s vision and values. By presenting a clear business case, a meaningful dialogue can be facilitated to determine the right fit for an organization.

It is crucial to map out objectives across all departments to clearly define requirements and identify potential gaps or areas for improvement. This approach enables an organization to choose a CDMO that can meet their needs and provide the required services at the expected level of quality. By considering all departments, such as manufacturing, quality control, regulatory affairs and project management, a well-chosen CDMO can support the entire product development and commercialization journey.

Dr. Shanmugan will cover topics such as the CDMO market, outsourcing models, drivers for outsourcing, the outsourcing and CDMO selection process for successful partnerships, and selection criteria. Challenges that arise during the selection process will also be discussed.

If you’re in the process of selecting a CDMO or seeking to refine your current process, this webinar is for you. Register today!

Speaker

Dr. Srinivasan Shanmugam, Senior Director of Pharmaceutical Sciences, Business Support and New Technologies

Dr. Srinivasan Shanmugam has over 20 years of experience in designing and developing conventional, NDDS/alternate, advanced/modified drug delivery systems and pharmaceutical platform technologies for oral and other routes of administration. His expertise includes stability, solubility/dissolution, permeability and bioavailability enhancement techniques/technologies for challenging drugs, as well as patient-centric solutions focusing on pediatric and geriatric populations to achieve dose convenience, flexibility and precision.

In his current position, Dr. Shanmugam is involved in the development and expansion of Adare’s pharmaceutical technology portfolio and supports product development, co-development and tech transfer opportunities. He holds a PhD and a BS in pharmacy. Dr. Shanmugam has published numerous research articles, holds multiple patents and serves as a reviewer and editorial member for various prestigious journals. His recent work focuses on product development solutions for special patient populations, such as pediatric and geriatric populations.

Message Presenter